Last updated 2026-08-28
- Raised $1M Seed round, 2013
- Raised grant led by Israel Innovation Authority, 2013
Total raised
$1.0M
Stage
—
Founded
2013
Headcount
—
HQ
Yehud, Israel
Sector
Pharmaceuticals
Website ↗Registrar ID: 513822916 (Prestigio Ltd.)
About
Prestigio Ltd. (DermaZor) is an Israeli dermatology-specialist company focused on the research and development of pharmaceutical products for treating damaged skin and skin diseases. The company's flagship product, DermaZor, is a patented, cannabis-enriched, over-the-counter (OTC) medicated cream for psoriasis and seborrheic dermatitis. It is clinically and dermatologically tested, hypoallergenic, and formulated with natural ingredients like salicylic acid, zinc, and cannabis oil complex. Prestigio Ltd. aims to provide scientific solutions for skin conditions, with products protected by international patents and FDA OTC listed.
Funding history · 2 rounds · $1.0M total
2 events/rounds · $1.0M Total Funding: $1.0M in Private Equity
2013
2013
Offices
Yehud, Israel · HQ / main office
Q&A
- What is Prestigio Ltd. (DermaZor)'s primary focus?
- Prestigio Ltd. (DermaZor) is an Israeli dermatology-specialist company focused on the research and development of pharmaceutical products for damaged skin and skin diseases, particularly psoriasis.
- What is the flagship product of Prestigio Ltd. (DermaZor)?
- The flagship product of Prestigio Ltd. (DermaZor) is DermaZor, a patented, FDA OTC listed, cannabis-enriched cream for the treatment of psoriasis and seborrheic dermatitis.
- When was Prestigio Ltd. (DermaZor) founded?
- Prestigio Ltd. (DermaZor) was founded in 2013.
- Where is Prestigio Ltd. (DermaZor) headquartered?
- Prestigio Ltd. (DermaZor) is headquartered in Yehud, Israel.
- What are the key technologies utilized by Prestigio Ltd. (DermaZor)?
- Prestigio Ltd. (DermaZor) utilizes cannabis-enriched formulations and natural ingredients in its products.
- Who is a notable member of Prestigio Ltd. (DermaZor)'s executive team?
- Prof. Michael David serves as the Board Scientific Advisor for Prestigio Ltd. (DermaZor).
- What business models does Prestigio Ltd. (DermaZor) employ?
- Prestigio Ltd. (DermaZor) employs both B2C and B2B business models.
- What are the target markets for Prestigio Ltd. (DermaZor)?
- Prestigio Ltd. (DermaZor) targets global markets.
Team · 1
Prof. Michael David
Board Scientific Advisor
Sectors & technology
Primary sector
Pharmaceuticals
Technologies
Target customers
Business model
B2CB2B (distributors)
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | dermazor.com |
|---|
Identifiers & details
| Legal name | Prestigio Ltd. |
|---|---|
| Founded | 2013 |
Radar intelligence
Web history (Wayback)
| Domain | dermazor.com |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513822916 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2006-04-24 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | אלטלף אברהם 11 יהוד-מונוסון |